Crossmark

When to start secukinumab treatment in patients with axial spondyloarthropathy: Before or after anti-TNFα treatment?

Crossref DOI link: https://doi.org/10.1016/j.reumae.2022.03.007

Published Print: 2023-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ak, Tumay

Mustafayeva, Leyla

Celik, Yeliz

Ayla, Ali Yagiz

Ugurlu, Serdal
License Information

Text and Data Mining valid from 2023-04-01
More Information

This article is maintained by: Elsevier

Article Title: When to start secukinumab treatment in patients with axial spondyloarthropathy: Before or after anti-TNFα treatment?

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2022.03.007

Content Type: article

Copyright: © 2022 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.